arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2601.09442stat.ME
收藏

用于帮助患者和其他利益相关者参与随机试验中估量项和继发事件策略选择的工具

Tools to help patients and other stakeholders' input into choice of estimand and intercurrent event strategy in randomised trials

MRC Clinical Trials Unit at UCL, UCL(伦敦大学学院医学研究委员会临床试验单元);Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London(伦敦国王学院精神病学、心理学和神经科学研究所生物统计与健康信息学系);Aberdeen Centre for Evaluation, University of Aberdeen(阿伯丁大学阿伯丁评估中心);Imperial Clinical Trials Unit, School of Public Health, Imperial College London(帝国理工学院公共卫生学院帝国临床试验单元)
Joanna Hindley, Charlotte Hartley, Jennifer Hellier, Kate Sturgeon, Sophie Greenwood, Ian Newsome, Katherine Barrett, Debs Smith, Tra My Pham, Dongquan Bi, Beat… 展开作者

Joanna Hindley, Charlotte Hartley, Jennifer Hellier, Kate Sturgeon, Sophie Greenwood, Ian Newsome, Katherine Barrett, Debs Smith, Tra My Pham, Dongquan Bi, Beatriz Goulao, Suzie Cro, Brennan C Kahan

AI总结:

本文提出三种工具,帮助患者和其他利益相关者参与随机试验中估量项和继发事件策略的选择,以提高决策的相关性。

摘要:

估量项可以帮助明确随机试验中所要解决的研究问题。由于估量项的选择会影响试验结果对患者和其他利益相关者(如临床医生或政策制定者)的相关性,因此让他们参与这些决策非常重要。然而,存在阻碍这些对话的障碍。例如,关于如何在估量项定义中处理继发事件的讨论通常涉及复杂的概念和技术语言。我们提供了三种工具,以促进研究人员、患者和其他利益相关者之间关于估量项和继发事件策略选择的对话:(i)一个解释估量项概念和五种不同方式将继发事件纳入估量项定义的视频;(ii)一张概述这五种策略的信息图;以及(iii)一个可编辑的PowerPoint幻灯片,可以填写特定试验的详细信息,以促进关于特定试验估量项选择的对话。这些资源可以帮助试验团队与患者和其他利益相关者开始讨论随机试验中最佳的估量项和继发事件策略选择。

英文摘要:

Estimands can help to clarify the research questions being addressed in randomised trials. Because the choice of estimand can affect how relevant trial results are to patients and other stakeholders, such as clinicians or policymakers, it is important for them to be involved in these decisions. However, there are barriers to having these conversations. For instance, discussions around how intercurrent events should be addressed in the estimand definition typically involve complex concepts as well as technical language. We three tools to facilitate conversations between researchers and patients and other stakeholders about the choice of estimand and intercurrent event strategy: (i) a video explaining the concept of an estimand and the five different ways that intercurrent events can be incorporated into the estimand definition; (ii) an infographic outlining these five strategies; and (iii) an editable PowerPoint slide which can be completed with trial-specific details to facilitate conversations around choice of estimand for a particular trial. These resources can help to start conversations between the trial team and patients and other stakeholders about the best choice of estimand and intercurrent event strategies for a randomised trial.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑